(2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin

Introduction

To understand associated biological information of (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Glucose Intolerance D018149 13 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?

There are no associated biomedical information in the current reference collection.

What functions are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin

Download all related citations
Per page 10 20 50 100 | Total 202
Authors Title Published Journal PubMed Link
Kodedová M and Sychrová H Synthetic antimicrobial peptides of the halictines family disturb the membrane integrity of Candida cells. 2017 Biochim. Biophys. Acta pmid:28600071
Blachnio-Zabielska AU et al. The Crucial Role of C18-Cer in Fat-Induced Skeletal Muscle Insulin Resistance. 2016 Cell. Physiol. Biochem. pmid:27960149
Aburasayn H et al. Targeting ceramide metabolism in obesity. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27382035
García-Marqués S et al. Sng1 associates with Nce102 to regulate the yeast Pkh-Ypk signalling module in response to sphingolipid status. 2016 Biochim. Biophys. Acta pmid:27033517
Stefanovic M et al. Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma. 2016 Oncotarget pmid:26811497
Mallela SK et al. Functions of Ceramide Synthase Paralogs YPR114w and YJR116w of Saccharomyces cerevisiae. 2016 PLoS ONE pmid:26752183
Chauhan N et al. Regulation of Sphingolipid Biosynthesis by the Morphogenesis Checkpoint Kinase Swe1. 2016 J. Biol. Chem. pmid:26634277
Salaun E et al. Myriocin prevents muscle ceramide accumulation but not muscle fiber atrophy during short-term mechanical unloading. 2016 J. Appl. Physiol. pmid:26542521
Lindahl L et al. Sphingolipids contribute to acetic acid resistance in Zygosaccharomyces bailii. 2016 Biotechnol. Bioeng. pmid:26416641
Yin S et al. Fumonisin B1 induces autophagic cell death via activation of ERN1-MAPK8/9/10 pathway in monkey kidney MARC-145 cells. 2016 Arch. Toxicol. pmid:25925693
Babenko NA and Kharchenko VS Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats. 2015 Biochemistry Mosc. pmid:25754045
Cozza G et al. A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteins. 2015 Biochim. Biophys. Acta pmid:25936777
Wang J et al. Fungal metabolite myriocin promotes human herpes simplex virus-2 infection. 2015 Life Sci. pmid:25447452
Martínez L et al. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis. 2015 Oncotarget pmid:26539645
Hodson AE et al. Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function. 2015 Cardiovasc Diabetol pmid:26682540
Perdoni F et al. Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm. 2015 BMC Microbiol. pmid:26519193
Athanasopoulos A et al. Characterization of AnNce102 and its role in eisosome stability and sphingolipid biosynthesis. 2015 Sci Rep pmid:26468899
Jun BK et al. Substrate Availability of Mutant SPT Alters Neuronal Branching and Growth Cone Dynamics in Dorsal Root Ganglia. 2015 J. Neurosci. pmid:26446223
Kurek K et al. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance. 2015 J Diabetes Res pmid:26380311
Bharath LP et al. Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo. 2015 Diabetes pmid:26253611
Aktepe TE et al. Differential utilisation of ceramide during replication of the flaviviruses West Nile and dengue virus. 2015 Virology pmid:26122470
Kasumov T et al. Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis. 2015 PLoS ONE pmid:25993337
Nelson MB et al. Cardiomyocyte mitochondrial respiration is reduced by receptor for advanced glycation end-product signaling in a ceramide-dependent manner. 2015 Am. J. Physiol. Heart Circ. Physiol. pmid:25957215
Gupta SD et al. Expression of the ORMDLS, modulators of serine palmitoyltransferase, is regulated by sphingolipids in mammalian cells. 2015 J. Biol. Chem. pmid:25395622
Samokhvalov V et al. PPARδ signaling mediates the cytotoxicity of DHA in H9c2 cells. 2015 Toxicol. Lett. pmid:25300478
Hamada Y et al. Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte-macrophage interaction. 2014 J. Nutr. Biochem. pmid:25283329
Chow SE et al. Resveratrol induced ER expansion and ER caspase-mediated apoptosis in human nasopharyngeal carcinoma cells. 2014 Apoptosis pmid:24264887
Swinnen E et al. The protein kinase Sch9 is a key regulator of sphingolipid metabolism in Saccharomyces cerevisiae. 2014 Mol. Biol. Cell pmid:24196832
Tippetts TS et al. Cigarette smoke increases cardiomyocyte ceramide accumulation and inhibits mitochondrial respiration. 2014 BMC Cardiovasc Disord pmid:25416336
Raichur S et al. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. 2014 Cell Metab. pmid:25295789
Thatcher MO et al. Ceramides mediate cigarette smoke-induced metabolic disruption in mice. 2014 Am. J. Physiol. Endocrinol. Metab. pmid:25269485
Surlow BA et al. Loss of Ypk1, the yeast homolog to the human serum- and glucocorticoid-induced protein kinase, accelerates phospholipase B1-mediated phosphatidylcholine deacylation. 2014 J. Biol. Chem. pmid:25258318
Li W et al. Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall. 2014 Oxid Med Cell Longev pmid:24817993
Correnti JM et al. Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice. 2014 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:24742988
Kurek K et al. Inhibition of ceramide de novo synthesis with myriocin affects lipid metabolism in the liver of rats with streptozotocin-induced type 1 diabetes. 2014 Biomed Res Int pmid:24701589
Curto MÁ et al. Membrane organization and cell fusion during mating in fission yeast requires multipass membrane protein Prm1. 2014 Genetics pmid:24514900
Yamane-Sando Y et al. Fpk1/2 kinases regulate cellular sphingoid long-chain base abundance and alter cellular resistance to LCB elevation or depletion. 2014 Microbiologyopen pmid:24510621
Tong M et al. Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin. 2014 Int J Exp Pathol pmid:24456332
Caretti A et al. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis. 2014 Biochim. Biophys. Acta pmid:24141140
Kasumov T et al. 2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23766259
Meszaros P et al. Long term myriocin treatment increases MRP1 transport activity. 2013 Int. J. Biochem. Cell Biol. pmid:23178537
Zhang O et al. Sphingosine kinase A is a pleiotropic and essential enzyme for Leishmania survival and virulence. 2013 Mol. Microbiol. pmid:23980754
Mikłosz A et al. Effects of inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate induced insulin resistance in L6 myotubes. 2013 PLoS ONE pmid:24376889
de Melo NR et al. Myriocin significantly increases the mortality of a non-mammalian model host during Candida pathogenesis. 2013 PLoS ONE pmid:24260135
Lizarazo D et al. Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis. 2013 J. Gastroenterol. Hepatol. pmid:23802886
Liu J et al. Reducing sphingolipid synthesis orchestrates global changes to extend yeast lifespan. 2013 Aging Cell pmid:23725375
Worgall TS et al. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. 2013 Sci Transl Med pmid:23698380
Huang X et al. Reducing signs of aging and increasing lifespan by drug synergy. 2013 Aging Cell pmid:23601176
Tafesse FG et al. Intact sphingomyelin biosynthetic pathway is essential for intracellular transport of influenza virus glycoproteins. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23576732
Dekker MJ et al. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction. 2013 Atherosclerosis pmid:23466071
Chiba K and Adachi K Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis. 2012 Future Med Chem pmid:22530640
Podbielska M et al. Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis. 2012 Neurochem. Res. pmid:22451227
Shin KO et al. Terpene alcohols inhibit de novo sphingolipid biosynthesis. 2012 Planta Med. pmid:22274813
Kubo T et al. Chlamydia trachomatis serovar L2 infection model using human lymphoid Jurkat cells. 2012 Microb. Pathog. pmid:22516802
Babenko NA and Kharchenko VS Ceramides inhibit phospholipase D-dependent insulin signaling in liver cells of old rats. 2012 Biochemistry Mosc. pmid:22348478
Mizukoshi K et al. The essential structures of ISP-I that influence serine palmitoyltransferase inhibition in Chinese hamster ovary cells. 2012 Biol. Pharm. Bull. pmid:22863936
Lee YJ et al. Sphingolipid signaling mediates iron toxicity. 2012 Cell Metab. pmid:22768841
Ussher JR et al. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance. 2012 PLoS ONE pmid:22629445
Zhang QJ et al. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. 2012 Diabetes pmid:22586587
Car H et al. Ceramide profiles in the brain of rats with diabetes induced by streptozotocin. 2012 FEBS J. pmid:22429392
Huang X et al. Down-regulating sphingolipid synthesis increases yeast lifespan. 2012 PLoS Genet. pmid:22319457
Gorshkova I et al. Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression. 2012 J. Lipid Res. pmid:22615416
Meyer SG et al. Myriocin, an inhibitor of serine palmitoyl transferase, impairs the uptake of transferrin and low-density lipoprotein in mammalian cells. 2012 Arch. Biochem. Biophys. pmid:22841978
Schwan C et al. Cholesterol- and sphingolipid-rich microdomains are essential for microtubule-based membrane protrusions induced by Clostridium difficile transferase (CDT). 2011 J. Biol. Chem. pmid:21705797
Yeung BK Natural product drug discovery: the successful optimization of ISP-1 and halichondrin B. 2011 Curr Opin Chem Biol pmid:21684798
Chun L et al. Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats. 2011 Diabetes Res. Clin. Pract. pmid:21492950
Strader CR et al. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. 2011 J. Nat. Prod. pmid:21456524
Lee YS et al. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest. 2011 Cell Prolif. pmid:21645154
Jiang XC et al. Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy. 2011 Adv. Exp. Med. Biol. pmid:21910080
Roelants FM et al. Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control sphingolipid homeostasis in Saccharomyces cerevisiae. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:22080611
Lattif AA et al. Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation. 2011 Microbiology (Reading, Engl.) pmid:21903752
Mizukoshi K et al. Effects of serine palmitoyltransferase inhibitor ISP-I on the stratum corneum of intact mouse skin. 2011 Biol. Pharm. Bull. pmid:21881222
Xiao ZH et al. [Effect of myriocin on the expression of cyclinD1 in high glucose-induced hypertrophy mesangial cells]. 2011 Zhongguo Dang Dai Er Ke Za Zhi pmid:21849123
Caviglia JM et al. Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy. 2011 J. Lipid Res. pmid:21719579
Schmitz-Peiffer C Targeting ceramide synthesis to reverse insulin resistance. 2010 Diabetes pmid:20876726
Frangioudakis G et al. Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. 2010 Endocrinology pmid:20660065
Klappe K et al. Extensive sphingolipid depletion does not affect lipid raft integrity or lipid raft localization and efflux function of the ABC transporter MRP1. 2010 Biochem. J. pmid:20604746
Liangpunsakul S et al. Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20224005
Sauane M et al. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis. 2010 J. Cell. Physiol. pmid:19937735
Lee BJ et al. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice. 2010 J. Gastroenterol. Hepatol. pmid:20594226
Mizukoshi K et al. The effects of serine palmitoyltransferase inhibitor, ISP-I, on UV-induced barrier disruption in the stratum corneum. 2010 Biol. Pharm. Bull. pmid:21139242
Strettoi E et al. Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20937879
Chentouf M et al. The lipid-modulating effects of a CD4-specific recombinant antibody correlate with ZAP-70 segregation outside membrane rafts. 2010 Immunol. Lett. pmid:20659502
Ussher JR et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. 2010 Diabetes pmid:20522596
Scherer M et al. A rapid and quantitative LC-MS/MS method to profile sphingolipids. 2010 J. Lipid Res. pmid:20228220
Breslow DK et al. Orm family proteins mediate sphingolipid homeostasis. 2010 Nature pmid:20182505
Glaros EN et al. Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition. 2010 Clin. Sci. pmid:20102334
Li Z et al. Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol. 2009 Biochim. Biophys. Acta pmid:19416652
Xiao-Yun X et al. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. 2009 Med. Sci. Monit. pmid:19721393
Cerbon J et al. Entamoeba invadens: sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation. 2009 Exp. Parasitol. pmid:19249300
Yang G et al. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19435851
Wang W et al. Lipid rafts play an important role in the vesicular stomatitis virus life cycle. 2009 Arch. Virol. pmid:19288237
Yu J et al. Determination of myriocin in natural and cultured Cordyceps cicadae using 9-fluorenylmethyl chloroformate derivatization and high-performance liquid chromatography with UV-detection. 2009 Anal Sci pmid:19609022
Wheeler D et al. Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. 2009 J. Neurochem. pmid:19476542
Junkin KA et al. Resistin acutely impairs insulin-stimulated glucose transport in rodent muscle in the presence, but not absence, of palmitate. 2009 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:19193939
Takahashi Y et al. Serine palmitoyltransferase, the first step enzyme in sphingolipid biosynthesis, is involved in nonhost resistance. 2009 Mol. Plant Microbe Interact. pmid:19061400
Park MA et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. 2008 Cancer Biol. Ther. pmid:18787411
Park TS et al. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice. 2008 Pharmacol. Res. pmid:18611440
Glaros EN et al. Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice. 2008 J. Lipid Res. pmid:17978313
Bismuth J et al. Ceramide: a common pathway for atherosclerosis? 2008 Atherosclerosis pmid:17963772